Chief of Urologic Surgery
Washington University School of Medicine
St. Louis, MO
Gerald L. Andriole, Jr., MD, is Chief Medical Officer of Prostatype Genomics. He retired in June 2023 from Johns Hopkins University where he was Professor and Director of Urology in the National Capital Region. Previously, he had been the Royce Distinguished Professor and Chief of Urologic Surgery at Washington University in St. Louis for over 20 years. Dr. Andriole participated in the 5-year accelerated medical program at Penn State University and Jefferson Medical College, Philadelphia, PA. He trained in surgery at Strong Memorial Hospital, University of Rochester, NY and completed urology residency at Brigham and Women’s Hospital, Harvard Medical School, Boston, MA. He served a fellowship in Urologic Oncology at the National Cancer Institute of NIH in Bethesda, Maryland prior to joining the faculty at Washington University.
Dr. Andriole has significant expertise in prostate cancer screening and prevention. He was continuously funded by NIH from 1993 and has contributed over 450 peer-reviewed publications (H-index of 110). He chaired the Prostate Committee of NCI’s PLCO Cancer Screening Trial and led the international REDUCE Prostate Cancer Chemoprevention Trial. He also chaired the Prostate Committee of the Society of Urologic Oncology Clinical Trials Consortium. Dr. Andriole is an elected member of the American Surgical Association, American Association of Genitourinary Surgeons, and the Clinical Society of Genitourinary Surgeons. He received the Outstanding Achievement Award from the Urologic Oncology Branch of NCI, the Distinguished Clinician Award from Washington University, the Distinguished Alumni Award from Jefferson Medical College and the Williams Award for Prostate Cancer Research Excellence from the American Urologic Association Urology Care Foundation.